A retrospective analysis of the incidence and risk factors for amniotic fluid embolism in cesarean deliveries
- PMID: 40217217
- PMCID: PMC11992712
- DOI: 10.1186/s12884-025-07527-x
A retrospective analysis of the incidence and risk factors for amniotic fluid embolism in cesarean deliveries
Abstract
Background: Amniotic-fluid embolism (AFE) is a rare occurrence but life-threatening disease that can occur in process of delivery and postnatal women. The topic of cesarean section surgery and its associated risk factors has been neglected due to the infrequent occurrence of AFE. However, AFE significantly contribute to maternal morbidity and mortality.
Purposes: We aim to examine the correlation between clinical issues, prenatal complications, comorbidities, medical perioperative complications, and cesarean section surgery of AFE in the US, utilizing a Nationwide Inpatient Sample (NIS) database.
Methods: This study conducted a retrospective cohort analysis on cesarean deliveries in the United States using data from the NIS of the Healthcare Cost and Utilization Project (HCUP) to examine the incidence and risk factors of AFE during cesarean section surgery. The analysis included the period from January 1, 2010, to December 31, 2019. We employed a multivariable logistic regression to evaluate the main outcome, which encompassed the clinical, prenatal, comorbidity, and medical perioperative AFE undergoing cesarean deliveries.
Results: We identified AFE in 269 out of the 2,462,005 women whose cesarean deliveries we investigated, with an incidence rate of 0.0113%. In the AFE group, the median patient age at the cohort level was 32 years (IQR, 27-36 years). The in-hospital mortality rate for patients with AFE following cesarean delivery was significantly higher than for those without AFE (14.9% vs. 0.0%, P < 0.001). In univariable analysis, P < 0.05 served as the initial selection criterion. A multivariable analysis revealed that AFE at the time of cesarean deliveries was significantly correlated with chronic blood loss anemia, coagulopathy, congestive heart failure, other neurological disorders, fluid and electrolyte disorders, weight loss, pulmonary circulation disorders, abruptio placentae, and polyhydramnios.
Conclusion: This contemporaneous, nationwide investigation verified the incidence of cesarean deliveries by AFE and corroborated previously identified risk factors for AFE. Although the absolute risk of AFE is minimal, clinicians should be aware of the identified risk factors, such as chronic blood loss anemia, coagulopathy, and polyhydramnios, to enhance preparedness and optimize patient counseling, particularly in high-risk cases.
Keywords: Amniotic-fluid embolism; Cesarean delivery; Incidence; Nationwide inpatient sample; Risk factors.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This observational study was deemed exempt by the Institutional Review Board of Dongguan Tungwah Hospital that waived the need for consent because it used deidentified publicly available data. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Association of Pregnancy Characteristics and Maternal Mortality With Amniotic Fluid Embolism.JAMA Netw Open. 2022 Nov 1;5(11):e2242842. doi: 10.1001/jamanetworkopen.2022.42842. JAMA Netw Open. 2022. PMID: 36399343 Free PMC article.
-
Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States.Am J Obstet Gynecol. 2008 Jul;199(1):49.e1-8. doi: 10.1016/j.ajog.2007.11.061. Epub 2008 Mar 4. Am J Obstet Gynecol. 2008. PMID: 18295171
-
Amniotic fluid embolism: 20-year incidence and case-fatality trends in the United States.Eur J Obstet Gynecol Reprod Biol. 2024 Mar;294:92-96. doi: 10.1016/j.ejogrb.2023.12.034. Epub 2024 Jan 4. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 38219609
-
From appearance to essence: 10 years review of atypical amniotic fluid embolism.Arch Gynecol Obstet. 2016 Feb;293(2):329-34. doi: 10.1007/s00404-015-3785-z. Epub 2015 Jun 20. Arch Gynecol Obstet. 2016. PMID: 26092134 Review.
-
Amniotic fluid embolism: a reappraisal.J Perinat Med. 2023 Dec 13;52(2):126-135. doi: 10.1515/jpm-2023-0365. Print 2024 Feb 26. J Perinat Med. 2023. PMID: 38082418 Review.
References
-
- Balinger KJ, Chu Lam MT, Hon HH, Stawicki SP, Anasti JN. Amniotic fluid embolism: despite progress, challenges remain. Curr Opin Obstet Gynecol. 2015;27:398–405. 10.1097/GCO.0000000000000218. - PubMed
-
- Ide R, Oda T, Todo Y, Kawai K, Matsumoto M, Narumi M, Kohmura-Kobayashi Y, Furuta-Isomura N, Yaguchi C, Uchida T, Suzuki K, Kanayama N, Itoh H, Tamura N. Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption. Sci Rep. 2024;14:272. 10.1038/s41598-023-50911-w. - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical